当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tumour Treating Fields for mesothelioma.
The Lancet Oncology ( IF 51.1 ) Pub Date : 2020-01-01 , DOI: 10.1016/s1470-2045(19)30829-0
Marcella Barbarino 1 , Maria Bottaro 1 , Luca Luzzi 1 , Antonio Giordano 2 , Luciano Mutti 3
Affiliation  

We read with interest the study by Giovanni Ceresoli and colleagues testing Tumour Treating Fields (TTFields) for inoperable malignant pleural mesothelioma. TTFields is an anti-tumour technology delivering low-intensity electric fields that interfere with mitosis. This study on mesothelioma comes after other trials of TTFields in other advanced or recurrent tumours. Although the authors suggest that their results warrant further investigation, several points should be addressed. In particular, critical information is missing, such as history of asbestos exposure, precise staging of the disease, and other prognostic factors.

中文翻译:

间皮瘤的肿瘤治疗领域。

我们感兴趣地阅读了Giovanni Ceresoli及其同事测试无法治疗的恶性胸膜间皮瘤的肿瘤治疗场(TTFields)的研究。TTFields是一种抗肿瘤技术,可产生干扰有丝分裂的低强度电场。间皮瘤的这项研究是在其他晚期或复发性肿瘤的TTFields试验之后进行的。尽管作者建议他们的结果值得进一步研究,但应注意几点。特别是缺少重要信息,例如石棉暴露史,疾病的精确分期以及其他预后因素。
更新日期:2020-01-04
down
wechat
bug